Lipid Transport by Candida albicans Dnf2 Is Required for Hyphal Growth and Virulence.
Bhawik Kumar JainAndrew S WagnerTodd B ReynoldsTodd R GrahamPublished in: Infection and immunity (2022)
Candida albicans is a common cause of human mucosal yeast infections, and invasive candidiasis can be fatal. Antifungal medications are limited, but those targeting the pathogen cell wall or plasma membrane have been effective. Therefore, virulence factors controlling membrane biogenesis are potential targets for drug development. P4-ATPases contribute to membrane biogenesis by selecting and transporting specific lipids from the extracellular leaflet to the cytoplasmic leaflet of the bilayer to generate lipid asymmetry. A subset of heterodimeric P4-ATPases, including Dnf1-Lem3 and Dnf2-Lem3 from Saccharomyces cerevisiae, transport phosphatidylcholine (PC), phosphatidylethanolamine (PE), and the sphingolipid glucosylceramide (GlcCer). GlcCer is a critical lipid for Candida albicans polarized growth and virulence, but the role of GlcCer transporters in virulence has not been explored. Here, we show that the Candida albicans Dnf2 ( Ca Dnf2) requires association with Ca Lem3 to form a functional transporter and flip fluorescent derivatives of GlcCer, PC, and PE across the plasma membrane. Mutation of conserved substrate-selective residues in the membrane domain strongly abrogates GlcCer transport and partially disrupts PC transport by CaDnf2. Candida strains harboring dnf2 -null alleles ( dnf2ΔΔ ) or point mutations that disrupt substrate recognition exhibit defects in yeast-to-hypha growth transition, filamentous growth, and virulence in systemically infected mice. The influence of CaDNF1 deletion on the morphological phenotypes is negligible, although the dnf1ΔΔ dnf2ΔΔ strain was less virulent than the dnf2ΔΔ strain. These results indicate that the transport of GlcCer and/or PC by plasma membrane P4-ATPases is important for the pathogenicity of Candida albicans.
Keyphrases
- candida albicans
- biofilm formation
- saccharomyces cerevisiae
- escherichia coli
- cell wall
- pseudomonas aeruginosa
- staphylococcus aureus
- antimicrobial resistance
- mitral valve
- endothelial cells
- transcription factor
- metabolic syndrome
- adipose tissue
- heart failure
- left ventricular
- skeletal muscle
- amino acid
- induced pluripotent stem cells
- risk assessment
- atrial fibrillation
- single molecule
- label free